A critical evaluation of the cardiac toxicity of citalopram

Journal of Psychosocial Nursing and Mental Health Services

Volumn 49, Issue 11, 2011, Pages 13-16

  Howland, Robert H ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80855134388     PISSN: 02793695     EISSN: None     Source Type: Journal    
DOI: 10.3928/02793695-20111011-01     Document Type: Article

References (14)

1. Brion, F., Brion, N., & Durigon, M. (1996). Fatal overdose with citalopram? Lancet, 348, 1380.
2. Catalano, G., Catalano, M.C., Epstein, M.A., & Tsambiras, P.E. (2001). QTc interval prolongation associated with citalopram overdose: A case report and literature review. Clinical Neuropharmacology, 24, 158-162.
3. de Gregorio, C., Morabito, G., Cerrito, M., Dattilo, G., & Oreto, G. (2011). Citalopram-induced long QT syndrome and torsade de pointes: Role for concomitant therapy and disease. International Journal of Cardiology, 148, 226-228.
4. ® (citalopram hydrobromide) tablets/oral solution. Retrieved from http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020822 s038s040,021046s016s017lbl.pdf
5. Glassman, A.H. (1997). Citalopram toxicity. Lancet, 350, 818.
6. Hayes, B.D., Klein-Schwartz, W., Clark, R.F., Muller, A.A., & Miloradovich, J.E. (2010). Comparison of toxicity of acute overdoses with citalopram and escitalopram. Journal of Emergency Medicine, 39, 44-48.
7. Isbister, G.K., Bowe, S.J., Dawson, A., & Whyte, I.M. (2004). Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose. Journal of Toxicology, 42, 277-285.
8. Jimmink, A., Caminada, K., Hunfeld, N.G., & Touw, D.J. (2008). Clinical toxicology of citalopram after acute intoxication with the sole drug or in combination with other drugs: Overview of 26 cases. Therapeutic Drug Monitoring, 30, 365-371.
9. Kelly, C.A., Dhaun, N., Laing, W.J., Strachan, F.E., Good, A.M., & Bateman, D.N. (2004). Comparative toxicity of citalopram and the newer antidepressants after overdose. Journal of Toxicology, 42, 67-71.
10. Personne, M., Persson, H., & Sjöberg, E. (1997). Citalopram toxicity. Lancet, 350, 518-519.
11. Rasmussen, S.L., Overø, K.F., & Tanghøj, P. (1999). Cardiac safety of citalopram: Prospective trials and retrospective analyses. Journal of Clinical Psychopharmacology, 19, 407-415.
12. U.S. Food and Drug Administration. (2009). Clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs. Retrieved from http:// www.fda.gov/RegulatoryInformation/ Guidances/ucm129335.htm
13. U.S. Food and Drug Administration. (2011). FDA drug safety communication: Abnormal heart rhythms associated with high doses of Celexa (citalopram hydrobromide). Retrieved from http://www.fda.gov/Drugs/DrugSafety/ ucm269086.htm
14. van Gorp, F., Whyte, I.M., & Isbister, G.K. (2009). Clinical and ECG effects of escitalopram overdose. Annals of Emergency Medicine, 54, 404-408.